NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING;National Institute Of Biological Sciences; Beijing
发明人:
申请号：
EP13858101.2
公开号：
EP2925312B1
申请日:
2013.11.21
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Obesity is inhibited by administering to a person in need thereof an effective amount of entacapone ((2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide), or a pharmaceutically-acceptable salt thereof, particularly in conjunction with a second, different anti-obesity medicament. Pharmaceutical compositions comprise entacapone copackaged or coformulated with a second, different anti-obesity medicament.
